194 related articles for article (PubMed ID: 38090570)
1. Enhanced alloresponse to platelet transfusion due to immune dysregulation following ablative chemotherapy in mice.
Jackman RP; Darst O; Gaillard B; Tran JQ; Tomayko MM; Muench MO
Front Immunol; 2023; 14():1281123. PubMed ID: 38090570
[TBL] [Abstract][Full Text] [Related]
2. Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion.
Saris A; Peyron I; van der Meer PF; Stuge TB; Zwaginga JJ; van Ham SM; Ten Brinke A
Front Immunol; 2018; 9():1251. PubMed ID: 29951051
[TBL] [Abstract][Full Text] [Related]
3. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
[TBL] [Abstract][Full Text] [Related]
4. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
[TBL] [Abstract][Full Text] [Related]
5. Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice.
Couvidou A; Angénieux C; Ruch L; Mangin PH; Gachet C; Maître B
Blood Adv; 2023 Apr; 7(8):1356-1365. PubMed ID: 36490266
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic major histocompatibility complex antigens are necessary and sufficient for partial tolerance induced by transfusion of pathogen reduced platelets in mice.
Tran JQ; Muench MO; Heitman JW; Jackman RP
Vox Sang; 2019 Apr; 114(3):207-215. PubMed ID: 30734299
[TBL] [Abstract][Full Text] [Related]
7. Polyinosinic: polycytidylic acid induced inflammation enhances while lipopolysaccharide diminishes alloimmunity to platelet transfusion in mice.
Tran JQ; Muench MO; Gaillard B; Darst O; Tomayko MM; Jackman RP
Front Immunol; 2023; 14():1281130. PubMed ID: 38146372
[TBL] [Abstract][Full Text] [Related]
8. CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.
Gilson CR; Patel SR; Zimring JC
Transfusion; 2012 Oct; 52(10):2209-19. PubMed ID: 22321003
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
Panch SR; Guo L; Vassallo R
Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
[TBL] [Abstract][Full Text] [Related]
10. Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase.
Bang A; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 1996 Oct; 88(8):2959-66. PubMed ID: 8874192
[TBL] [Abstract][Full Text] [Related]
11. The Role of the Immunological Synapse in Differential Effects of APC Subsets in Alloimmunization to Fresh, Non-stored RBCs.
Richards AL; Sheldon K; Wu X; Gruber DR; Hudson KE
Front Immunol; 2018; 9():2200. PubMed ID: 30344520
[No Abstract] [Full Text] [Related]
12. A small allelic variant in donor class I MHC is sufficient to induce alloantibodies following transfusion of standard or pathogen-reduced platelets in mice.
Jackman RP; Heitman JW; Muench MO
Vox Sang; 2020 Jul; 115(5):367-376. PubMed ID: 32201962
[TBL] [Abstract][Full Text] [Related]
13. Reduced alloimmunization in mice following repeated transfusion with pathogen-reduced platelets.
Muench MO; Heitman JW; Inglis H; Fomin ME; Marschner S; Goodrich RP; Norris PJ; Jackman RP
Transfusion; 2016 Jun; 56(6):1419-29. PubMed ID: 27028210
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
15. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
Amemiya Y
Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.
Patel SR; Zimring JC
Transfus Med Rev; 2013 Oct; 27(4):241-8. PubMed ID: 24090731
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
[TBL] [Abstract][Full Text] [Related]
18. Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.
Jackman RP; Muench MO; Heitman JW; Inglis HC; Law JP; Marschner S; Goodrich RP; Norris PJ
Transfusion; 2013 Nov; 53(11):2697-709. PubMed ID: 23451715
[TBL] [Abstract][Full Text] [Related]
19. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.
Gilson CR; Zimring JC
Transfusion; 2012 Apr; 52(4):849-59. PubMed ID: 21981241
[TBL] [Abstract][Full Text] [Related]
20. Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens.
Bang KW; Speck ER; Blanchette VS; Freedman J; Semple JW
Blood; 2000 Mar; 95(5):1735-42. PubMed ID: 10688832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
